Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients.

Orrù CD, Soldau K, Cordano C, Llibre-Guerra J, Green AJ, Sanchez H, Groveman BR, Edland SD, Safar JG, Lin JH, Caughey B, Geschwind MD, Sigurdson CJ.

MBio. 2018 Nov 20;9(6). pii: e02095-18. doi: 10.1128/mBio.02095-18.

2.

Generation of novel neuroinvasive prions following intravenous challenge.

Aguilar-Calvo P, Bett C, Sevillano AM, Kurt TD, Lawrence J, Soldau K, Hammarström P, Nilsson KPR, Sigurdson CJ.

Brain Pathol. 2018 Mar 5. doi: 10.1111/bpa.12598. [Epub ahead of print]

PMID:
29505163
3.

Post-translational modifications in PrP expand the conformational diversity of prions in vivo.

Aguilar-Calvo P, Xiao X, Bett C, Eraña H, Soldau K, Castilla J, Nilsson KP, Surewicz WK, Sigurdson CJ.

Sci Rep. 2017 Mar 8;7:43295. doi: 10.1038/srep43295.

4.

Assessment of the red cell proteome of young patients with unexplained hemolytic anemia by two-dimensional differential in-gel electrophoresis (DIGE).

von Löhneysen K, Scott TM, Soldau K, Xu X, Friedman JS.

PLoS One. 2012;7(4):e34237. doi: 10.1371/journal.pone.0034237. Epub 2012 Apr 3.

5.

A novel approach for in vivo measurement of mouse red cell redox status.

Xu X, von Löhneysen K, Soldau K, Noack D, Vu A, Friedman JS.

Blood. 2011 Sep 29;118(13):3694-7. doi: 10.1182/blood-2011-03-342113. Epub 2011 Aug 10.

6.

Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events.

Mullick AE, Soldau K, Kiosses WB, Bell TA 3rd, Tobias PS, Curtiss LK.

J Exp Med. 2008 Feb 18;205(2):373-83. doi: 10.1084/jem.20071096. Epub 2008 Feb 4.

7.

Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

Lee HK, Dunzendorfer S, Soldau K, Tobias PS.

Immunity. 2006 Feb;24(2):153-63.

8.
9.

TLR4 is the signaling but not the lipopolysaccharide uptake receptor.

Dunzendorfer S, Lee HK, Soldau K, Tobias PS.

J Immunol. 2004 Jul 15;173(2):1166-70.

10.

Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses.

Dunzendorfer S, Lee HK, Soldau K, Tobias PS.

FASEB J. 2004 Jul;18(10):1117-9. Epub 2004 May 7.

PMID:
15132988
11.

MD-2 binds to bacterial lipopolysaccharide.

Viriyakosol S, Kirkland T, Soldau K, Tobias P.

J Endotoxin Res. 2000;6(6):489-91.

PMID:
11521076
12.

Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2.

da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ.

J Biol Chem. 2001 Jun 15;276(24):21129-35. Epub 2001 Mar 26.

13.

Innate immune system recognition of microbial pathogens.

Tobias PS, Lee H, Orr S, Soldau K, Tapping R.

Immunol Res. 2000;21(2-3):341-3.

PMID:
10852135
14.
15.

Phagocytosis of gram-negative bacteria by a unique CD14-dependent mechanism.

Schiff DE, Kline L, Soldau K, Lee JD, Pugin J, Tobias PS, Ulevitch RJ.

J Leukoc Biol. 1997 Dec;62(6):786-94.

PMID:
9400820
16.

Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS.

Tobias PS, Soldau K, Iovine NM, Elsbach P, Weiss J.

J Biol Chem. 1997 Jul 25;272(30):18682-5.

17.

Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14.

Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ.

J Biol Chem. 1995 May 5;270(18):10482-8.

18.

Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.

Tobias PS, Soldau K, Kline L, Lee JD, Kato K, Martin TP, Ulevitch RJ.

J Immunol. 1993 Apr 1;150(7):3011-21.

PMID:
7681085
19.

Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein.

Tobias PS, Soldau K, Ulevitch RJ.

J Biol Chem. 1989 Jun 25;264(18):10867-71.

20.

Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.

Tobias PS, Soldau K, Ulevitch RJ.

J Exp Med. 1986 Sep 1;164(3):777-93.

21.
22.

Supplemental Content

Loading ...
Support Center